Nothing here is verified yet. Content is migrated or drafted and has not been reviewed by a practitioner. Assertions marked like this are unchecked.
FinAtlas
Archetypeunverified

Biotech / pharma

Long, binary, capital-consuming development pipeline before any revenue.

What changes about the finance work: Value is almost entirely in probability-weighted future cash flows

Relationships pointing at this node.

changes these tasks

1

The task exists in this business archetype but behaves differently. The note is the point of the edge: it must say how it differs, not merely that it does.

  • There is no revenue to project across most of the horizon. The plan is a probability-weighted pipeline with burn and runway as the operative outputs, and its purpose is to locate the funding milestones rather than to describe a P&L.